Counteracting hematopoietic ageing by pharmacological inhibition of TGFbeta and IL-6 signaling
Counteracting hematopoietic ageing by pharmacological inhibition of TGFbeta and IL-6 signaling
批准号:
MR/T015055/1
负责人:
Claus Nerlov
金额:
$56.29万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
干细胞是一种特殊类型的细胞,具有制造许多其他类型细胞的能力。随着年龄的增长,我们骨髓中的干细胞停止正常工作。这意味着它们不再能够有效地制造红细胞(在身体周围运输氧气的细胞)或白色细胞(帮助我们的身体对抗感染的细胞)。这会导致各种健康并发症,从免疫系统虚弱到无法抵抗感染,再到认知能力、心血管能力和肌肉力量下降。我们体内任何细胞的功能,包括骨髓干细胞,都取决于它们的DNA是如何被控制的。所有的细胞都有相同的DNA密码,但以不同的方式读取这些密码。代码被分成信息的部分,就像句子中的单词一样,称为基因。每个基因告诉细胞做不同的任务,或者制造不同的重要成分。为了理解为什么衰老会产生这种影响,在之前的一个项目中,我们比较了从年轻和老年小鼠中获得的骨髓干细胞中基因的开启和关闭。我们发现,有两组基因似乎在旧的骨髓干细胞中更活跃。为了验证这些基因是否真的很重要,我们研究了它们编码的细胞成分的“生产”线。我们发现,如果我们改变这些生产线,我们能够逆转骨髓细胞中一些与年龄相关的影响。在这个项目中,我们想更好地了解我们如何调整这些生产线,真正逆转骨髓干细胞中的衰老影响。特别是,我们想了解如何篡改这些生产线之一(称为TGF β信号通路)可以导致增加生产的白色血细胞和更好地保护免受感染。我们也有兴趣了解如何篡改这两个生产途径可以增加红细胞的生产。最终,我们希望通过更好地了解这两个生产线如何干扰骨髓干细胞的正常工作,我们可能能够设计出逆转它的方法,并希望帮助受这些条件影响的患者。
英文摘要
Stem cells are a special type of cell with the ability to make many other types of cell. As we age, the stem cells in our bone marrow stop working properly. This means that they are no longer able to make red blood cells (the cells that transport oxygen around the body) or white blood cells (the cells that help our body fight infections), quite as efficiently. This leads to a variety of health complications, from a weak immune system that can no longer fight infections, to a reduction in cognitive and cardiovascular ability and muscle strength.The functioning of any cell in our bodies, including bone marrow stem cells, depends on how their DNA is controlled. All cells have the same DNA code in them, but read this code in different ways. The code is divided into portions of information, like words in a sentence, called genes. Each gene tells the cell to do a different task, or make a different important component.To understand why ageing has this effect, in a previous project we compared the genes are turned on and off in bone marrow stem cells obtained from young and old mice. We discovered that there are two sets of genes that seem to be more active in old bone marrow stem cells. To check that these genes were really important, we looked at the 'production' line of cell components that they code for. We found that if we tampered with these production lines, we were able to revert some of the age-related effects in the bone marrow cells.In this project, we want to understand better how we can adjust these production lines to really revert the effects of ageing in bone marrow stem cells. In particular, we want to understand how tampering with one of these production lines (known as TGFbeta signalling pathway) can lead to an increased production of white blood cells and better protection against infections. We are also interested in understanding how tampering with both production pathways can increase the production of red blood cells.Ultimately, we hope that by understanding better how these two production lines interfere with the normal work of bone marrow stem cells, we may be able to devise ways to reverse it, and hopefully help patients affected by these conditions.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41467-023-41691-y
发表时间:
2023-09-28
期刊:
NATURE COMMUNICATIONS
影响因子:
16.6
作者:
[Luis, Tiago C., Barkas, Nikolaos, Carrelha, Joana, Giustacchini, Alice, Mazzi, Stefania, Norfo, Ruggiero, Wu, Bishan, Aliouat, Affaf, Guerrero, Jose A., Rodriguez-Meira, Alba, Bouriez-Jones, Tiphaine, Macaulay, Iain C., Jasztal, Maria, Zhu, Guangheng, Ni, Heyu, Robson, Matthew J., Blakely, Randy D., Mead, Adam J., Nerlov, Claus, Ghevaert, Cedric, Jacobsen, Sten Eirik W.]
通讯作者:
Jacobsen, Sten Eirik W.
Hierarchical organization of haematopoietic stem- and progenitor cell populations during steady state and stress haematopoiesis
-
批准号:MC_UU_00029/9
-
项目类别:Intramural
-
资助金额:$469.92万
-
财政年份:2022
-
负责人:Claus Nerlov
-
依托单位:
Transcriptional and epigenetic mechanisms of HSC subtype diversification
-
批准号:BB/V002198/1
-
项目类别:Research Grant
-
资助金额:$58.89万
-
财政年份:2021
-
负责人:Claus Nerlov
-
依托单位:
Cellular mechanisms of haematopoietic lineage commitment
-
批准号:MC_UU_00016/7
-
项目类别:Intramural
-
资助金额:$257.13万
-
财政年份:2017
-
负责人:Claus Nerlov
-
依托单位:
The cellular and molecular basis of age-dependent anemia: a single cell-based approach
-
批准号:BB/M024350/1
-
项目类别:Research Grant
-
资助金额:$57.24万
-
财政年份:2015
-
负责人:Claus Nerlov
-
依托单位:
Transcriptional regulation of hematopoietic self-renewal, lineage specification and leukemogenesis
-
批准号:G0900892/2
-
项目类别:Research Grant
-
资助金额:$136.54万
-
财政年份:2012
-
负责人:Claus Nerlov
-
依托单位:
Transcriptional regulation of hematopoietic self-renewal, lineage specification and leukemogenesis
-
批准号:G0900892/1
-
项目类别:Research Grant
-
资助金额:$214.38万
-
财政年份:2010
-
负责人:Claus Nerlov
-
依托单位:
国内基金
海外基金
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
-
批准号:82371301
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李轶
-
依托单位:
对12个造血候选基因在小鼠骨髓抑制和再生过程中作用的筛查
-
批准号:30570787
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2005
-
负责人:毛文伟
-
依托单位: